The Value of Specifying Brand-name Antiepileptic Drugs

被引:0
|
作者
Ng, Yu-tze [1 ]
机构
[1] St Josephs Med Hlth Ctr, Barrow Neurol Inst, Div Pediat Neurol, Phoenix, AZ 85013 USA
关键词
GENERIC SUBSTITUTION; LAMOTRIGINE; EPILEPSY; CONSEQUENCES;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1415 / 1416
页数:2
相关论文
共 50 条
  • [1] SUBSTITUTION FOR BRAND-NAME DRUGS
    CAMINETSKY, S
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1963, 88 (18) : 950 - &
  • [3] Brand-Name Versus Generic Drugs
    Manning, Richard
    Smith, Richard
    HEALTH AFFAIRS, 2011, 30 (10) : 2027 - 2027
  • [4] ELDERLY, POOR, AND LOYAL TO BRAND-NAME DRUGS
    RICE, B
    PSYCHOLOGY TODAY, 1980, 14 (04) : 27 - 28
  • [5] Brand-name biologic drugs protected by USMCA
    Mullin, Emily
    CHEMICAL & ENGINEERING NEWS, 2018, 96 (41) : 19 - 19
  • [6] UNIFORM APPEARANCE OF GENERIC AND BRAND-NAME DRUGS
    KAHN, BS
    NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (26): : 1492 - 1492
  • [7] Inadequate labels: Brand-name and generic drugs
    Kazhdan, Daniel
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [8] Comparative effectiveness of generic versus brand-name antiepileptic medications
    Gagne, Joshua J.
    Kesselheim, Aaron S.
    Choudhry, Niteesh K.
    Polinski, Jennifer M.
    Hutchins, David
    Matlin, Olga S.
    Brennan, Troyen A.
    Avorn, Jerry
    Shrank, William H.
    EPILEPSY & BEHAVIOR, 2015, 52 : 14 - 18
  • [10] GENERIC VS BRAND-NAME DRUGS FOR THE TREATMENT OF HYPERTENSION
    Dinic, M.
    Maillard, N.
    Bouiller, M.
    Alamartine, E.
    Mariat, C.
    JOURNAL OF HYPERTENSION, 2018, 36 : E123 - E123